1) Vignot S, Faivre S, Aguirre D, et al. : mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16 : 525-537,2005.
2) Huang S, Houghton PJ : Mechanisms of resistance to rapamycins. Drug Resist Updat 4 : 378-391,2001.
3) Granville CA, Memmott RM, Gills JJ, et al. : Handicap-ping the race to develop inhibitors of the phos-phoinositide 3-kinase/Akt/mammalian target of rapamycin pathway. Clin Cancer Res 12 : 679-689, 2006.
5) Guba M, Yezhelyev M, Eichhorn ME, et al. : Rapamy-cM induces tumor-specific thrombosis via tissue fac-tor in the presence of VEGF. Blood 105 : 4463-4469, 2005.